| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA1737951 | F | PUBCHEM_BIOASSAY: Confirmation assay for inhibitors of Trypanosoma brucei hexokinase 1-Analogue-first series. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1430, AID1632, AID2516, AID2560, AID2579, AID2600, AID449725, AID492951] | Trypanosoma brucei | 191 | ALA1201862 | assay format | PubChem BioAssays | |
| 2. | ALA1738242 | F | PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504690, AID504696] | Plasmodium berghei | 587 | ALA1201862 | assay format | PubChem BioAssays | |
| 3. | ALA1737961 | F | PUBCHEM_BIOASSAY: Human Glucose-6-Phosphate Dehydrogenase Dose Response Selectivity Assay for Inhibitors of Plasmodium falciparum Glucose-6-Phosphate Dehydrogenase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504690, AID504696] | 587 | ALA1201862 | assay format | PubChem BioAssays | ||
| 4. | ALA1794336 | F | PUBCHEM_BIOASSAY: Dose Response orthogonal kinetic assay utilizing the direct detection of NADPH for uHTS small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504690, AID504696] | 587 | ALA1201862 | assay format | PubChem BioAssays | ||
| 5. | ALA1794528 | F | PUBCHEM_BIOASSAY: Dose Response orthogonal assay utilizing the direct end-point detection of NADPH for uHTS small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504690, AID504696] | 587 | ALA1201862 | assay format | PubChem BioAssays | ||
| 6. | ALA1794553 | F | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | Homo sapiens | 58,172 | ALA1201862 | cell-based format | PubChem BioAssays | |
| 7. | ALA1794584 | F | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | 63,980 | ALA1201862 | assay format | PubChem BioAssays | ||
| 8. | ALA1963932 | F | PUBCHEM_BIOASSAY: Absorbance-based biochemical high throughput dose response assay for activators of Methionine sulfoxide reductase A (MsrA). (Class of assay: confirmatory) | 111 | ALA1201862 | assay format | PubChem BioAssays | ||
| 9. | ALA2114861 | F | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen. (Class of assay: confirmatory) | 26,907 | ALA1201862 | assay format | PubChem BioAssays | ||
| 10. | ALA2114881 | F | PubChem BioAssay. Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Primary and Confirmatory Screens. (Class of assay: confirmatory) | Homo sapiens | 2,057 | ALA1201862 | assay format | PubChem BioAssays | |
| 11. | ALA2114727 | F | PubChem BioAssay. Fluorescence-based cell-based high throughput dose response assay for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2). (Class of assay: confirmatory) | Homo sapiens | 232 | ALA1201862 | cell-based format | PubChem BioAssays | |
| 12. | ALA2114738 | F | PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) | Homo sapiens | 15,494 | ALA1201862 | assay format | PubChem BioAssays | |
| 13. | ALA2114772 | F | PubChem BioAssay. Counterscreen for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and receptor-interacting serine-threonine kinase 2 (RIPK2): Fluorescence-based cell-based high throughput dose response assay to identify non-selective inhibitors of the beta-lactamase enzyme (BLA). (Class of assay: confirmatory) | Pseudomonas aeruginosa | 232 | ALA1201862 | cell-based format | PubChem BioAssays | |
| 14. | ALA2114784 | F | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | Homo sapiens | 53,810 | ALA1201862 | assay format | PubChem BioAssays | |
| 15. | ALA2114788 | F | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | Homo sapiens | 103,470 | ALA1201862 | assay format | PubChem BioAssays | |
| 16. | ALA2114810 | F | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | Homo sapiens | 86,035 | ALA1201862 | assay format | PubChem BioAssays | |
| 17. | ALA2114916 | F | PubChem BioAssay. qHTS of Trypanosoma Brucei Inhibitors. (Class of assay: confirmatory) | Trypanosoma brucei | 6,592 | ALA1201862 | assay format | PubChem BioAssays | |
| 18. | ALA2354211 | F | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line. (Class of assay: confirmatory) | 35,070 | ALA1201862 | cell-based format | PubChem BioAssays | ||
| 19. | ALA2354221 | F | PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT. (Class of assay: confirmatory) | 172,532 | ALA1201862 | assay format | PubChem BioAssays | ||
| 20. | ALA2354254 | F | PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT. (Class of assay: confirmatory) | 153,867 | ALA1201862 | assay format | PubChem BioAssays |
The page will load shortly, Thanks for your patience!